Intravitreal Administration Effect of Adipose-Derived Mesenchymal Stromal Cells Combined with Anti-VEGF Nanocarriers, in a Pharmaceutically Induced Animal Model of Retinal Vein Occlusion

Intravitreal Administration Effect of Adipose-Derived Mesenchymal Stromal Cells Combined with Anti-VEGF Nanocarriers, in a Pharmaceutically Induced Animal Model of Retinal Vein Occlusion

Antiangiogenic therapeutic agents (anti-VEGF) have contributed to the treatment of retinal vein occlusion (RVO) while mesenchymal stromal cell- (MSCs-) mediated therapies limit eye degeneration. The aim of the present study is to determine the effect of adipose-derived MSCs (ASCs) combination with n...

Full description

Saved in:

Bibliographic Details
Main Authors:	Eleni Gounari, Anastasia Komnenou, Evangelia Kofidou, Stavroula Nanaki, Dimitrios Bikiaris, Stavroula Almpanidou, Kokkona Kouzi, Vasileios Karampatakis, George Koliakos
Format:	Article
Language:	English
Published:	Wiley 2022-01-01
Series:	Stem Cells International
Online Access:	http://dx.doi.org/10.1155/2022/2760147
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evaluation of Clinical and Histological Outcomes of Adipose-Derived Mesenchymal Stem Cells in a Rabbit Corneal Alkali Burn Model
by: Diamantis Almaliotis, et al.
Published: (2021-01-01)

Effect of Long-Term Cryopreservation on the Stemness of Stem Cells of Apical Papilla
by: Anna Digka, et al.
Published: (2022-01-01)

Vitreous Inflammation Associated with Intravitreal Anti-VEGF Pharmacotherapy
by: Shivi Agrawal, et al.
Published: (2013-01-01)

Efficacy and safety of intravitreal anti-VEGF for myopic choroidal neovascularization
by: Jing-Yao Liu, et al.
Published: (2025-09-01)

The potential role of adipokines and hepatokines in age-related ocular diseases
by: Stavroula Almpanidou, et al.
Published: (2025-06-01)

Intravitreal Injection of Anti-VEGF Antibody Induces Glomerular Endothelial Cells Injury
by: F. Touzani, et al.
Published: (2019-01-01)

Erratum: Bedside bilateral sequential intravitreal anti-VEGF injections for retinopathy of prematurity
Published: (2025-01-01)

The impact of switching from anti-VEGF therapy to dexamethasone intravitreal implant on refractory macular edema in patients with retinal vein occlusion: A systematic review and meta-analysis
by: He-Ping Zhang, et al.
Published: (2025-08-01)

Analysis of intravitreal using of anti vegf-medications for diseases of fundus accompanied by exudation and neovascularization
by: N. G. Zavgorodnya, et al.
Published: (2013-08-01)

The Injectables: What, When, and Which One? Updates on Intravitreal Anti-VEGF drugs and steroids
by: Kristine Corpus, MD, et al.
Published: (2015-06-01)

Systemic Effects of Intravitreal Anti-VEGF Therapy: A Review of Safety across Organ Systems
by: Mousumi Banerjee, et al.
Published: (2025-06-01)

Contributing factors to short-term intraocular pressure elevation following intravitreal anti-VEGF injections
by: Yanchen Liu, et al.
Published: (2025-05-01)

Efficacy and safety of prophylactic simultaneous intravitreal moxifloxacin injection with standard intravitreal anti-VEGF injection procedure in cases of cystoid macular edema and macular neovascularization
by: Mohamed Nagy Elmohamady, et al.
Published: (2025-05-01)

Management and safety of same day bilateral intravitreal anti-VEGF injections in a treat-and-extend regimen
by: Christina Plasencia, et al.
Published: (2025-08-01)

Multiple serous retinal detachments after Anti-VEGF Intravitreal Injection for pachychoroid related choroidal neovascularization
by: Huilin Liang, et al.
Published: (2024-12-01)

Short and long-term impact of intravitreal anti-VEGF therapy interruption in retinal vein occlusion during the COVID-19 pandemic: functional outcomes and AI-based fluid analysis of macular edema
by: Emmanuelle Moret, et al.
Published: (2025-08-01)

Impact of Intravitreal Dexamethasone Implant on Vessel Diameters in Patients with Retinal Vein Occlusion
by: Busra Yilmaz Tugan, et al.
Published: (2019-01-01)

Macular edema in Wyburn-Mason syndrome: Resolution with anti-VEGF intravitreal injections. Case report and review of the literature
by: Nathan Hupin, et al.
Published: (2024-12-01)

Phacoemulsification surgery in patients with diabetic macular edema: should intravitreal anti-VEGF therapy be performed before or simultaneously with surgery?
by: Yusuf Ziya Güven, et al.
Published: (2025-04-01)

Treatment Cessation in Patients with Diabetic Maculopathy under Intravitreal Anti-VEGF Therapy Following a Treat-and-Extend Protocol
by: Lucia Saucedo, PhD, et al.
Published: (2025-11-01)

The potential role of the combined PARP-1 and VEGF inhibition in severe SARS-CoV-2 (COVID-19) infection
by: Dimitra Ioanna Lampropoulou, et al.
Published: (2022-01-01)

Efficacy and Safety in Retinal Vein Occlusion Treated with at Least Three Consecutive Intravitreal Dexamethasone Implants
by: Julia Proença Pina, et al.
Published: (2016-01-01)

Intravitreal injection of vancomycin leading to cilioretinal artery occlusion: A case report and literature review
by: Chen Zhao, et al.
Published: (2025-06-01)

Comparison of the Efficacy of Intravitreal Aflibercept and Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion
by: Jia-Kang Wang, et al.
Published: (2016-01-01)

Bilateral Central Retinal Vein Occlusion with Hyperhomo cysteinaemia, treated early with anti VEGF
by: Anurag Narula, et al.
Published: (2013-10-01)

Timing of vitrectomy for treatment of endophthalmitis after intravitreal anti-VEGF injection: a systematic literature review of case reports and series
by: Daniel J. Hu, et al.
Published: (2025-01-01)

Comparison of intravitreal anti-VEGF agents and oral carbonic anhydrase inhibitors in the treatment of cystoid macular edema secondary to retinitis pigmentosa
by: Jia Liang, et al.
Published: (2024-12-01)

One-year results of visual response following intravitreal novel anti-VEGF injection for diabetic macular edema in a Latino population
by: Guillermo Salcedo-Villanueva, et al.
Published: (2025-08-01)

Long Term Outcome and Histologic Findings of a Retinal Astrocytic Hamartoma Treated with Intravitreal Injection of Anti-VEGF: A Case Report
by: Kinza T. Ahmad, et al.
Published: (2021-01-01)

Differentiation between Good and Low-Responders to Intravitreal Ranibizumab for Macular Edema Secondary to Retinal Vein Occlusion
by: Marcel N. Menke, et al.
Published: (2016-01-01)

Correlation of intravitreal IL-6 with the formation of epiretinal membrane after successful retinal detachment repair
by: Konstantinos Ananikas, et al.
Published: (2025-06-01)

Effect of multiple intravitreal injections of conbercept on the cornea in patients with branch retinal vein occlusion-induced macular edema
by: Gaixia Zhai, et al.
Published: (2025-06-01)

Risk factors and Response of Branch Retinal Vein Occlusion induced Macular Edema to intravitreal injections of Triamcinolone and Bevacizumab
by: Singhai Prakhar, et al.
Published: (2017-07-01)

Pegaptanib sodium for macular edema due to retinal-vein occlusion among patients intolerant to intravitreal triamcinolone acetonide
by: Ellen N. Yu, MD, et al.
Published: (2010-12-01)

Long term efficacy and safety profile of dexamethasone intravitreal implant in retinal vein occlusions: a systematic review
by: Adriano Carnevali, et al.
Published: (2024-11-01)

PLA-Based Electrospun Nanofibrous Mats Towards Application as Antibiotic Carriers: Processing Parameters, Fabrication and Characterization
by: Evi Christodoulou, et al.
Published: (2025-04-01)

Long-term results of anti-VEGF therapy in macular edema caused by central retinal vein occlusion
by: A. B. Galimova, et al.
Published: (2023-12-01)

Epithelioid sarcoma of the hand mimicking Dupuytren's disease: A case report and review of the literature
by: Athanasios Papas, et al.
Published: (2025-06-01)

Combined intravitreal anti-VEGF and photodynamic therapy versus photodynamic monotherapy for polypoidal choroidal vasculopathy: a systematic review and meta-analysis of comparative studies.
by: Wei Wang, et al.
Published: (2014-01-01)

Maintaining driving vision after intravitreal anti-VEGF therapy in patients with neovascular AMD and diabetic macular edema: a plain language summary of publication
by: Parisa Emami-Naeini, et al.
Published: (2025-03-01)